Showing results (1171-1180 of 5,257) with videos related to
Sort By:
Pageof 526
Oncology|January 1, 1981
Cells from normal and malignant human colon mucosa differentially inhibit embryonic cell aggregationD E Maslow, E Mayhew, A MittlemanOncology|April 22, 2020
Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?Federica Di Pinto, Raffaele Armentano, Graziana Arborea, et al.Oncology|April 29, 2020
Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer PatientsJoanna Huszno, Zofia Kołosza, Jolanta Mrochem-Kwarciak, et al.Oncology|November 16, 2022
Prognostic Impact of Hepatic Steatosis Evaluated by CT on Immunotherapy for Gastric Cancer: Associations with Sarcopenia, Systemic Inflammation, and HormonesKoichi Hayano, Gaku Ohira, Masayuki Kano, et al.Oncology|January 1, 1985
Phase II results with recombinant interferons: renal cell carcinoma and malignant melanomaR Kuzmits, E M Kokoschka, M Micksche, et al.Oncology|January 1, 1985
Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignanciesJ T Janssen, H Ludwig, W Scheithauer, et al.Oncology|January 1, 1985
Anticancer activity of a natural product, viva-natural, extracted from Undaria pinnantifida on intraperitoneally implanted Lewis lung carcinomaE Furusawa, S FurusawaOncology|March 20, 2023
Sex-Specific Differences in the Risk of Heart Failure following Anti-HER2 Monoclonal Antibody TherapyYuta Suzuki, Hidehiro Kaneko, Yuicui Tamura, et al.Oncology|January 1, 1987
Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimideW R Bezwoda, N Mansoor, R DanseyOncology|January 1, 1987
Significance of plasma retinol binding protein levels in recurrence of breast tumors in womenR R Mehta, G Hart, C W Beattie, et al.Pageof 526